Keeps Pharma to Attend BIO USA and Seek Anticancer and Oral Platform Partnerships with Big Pharma

Keeps Pharma announced its participation in the BIO USA conference. The company will use the event to explore partnership opportunities. Focus areas include an anticancer drug program. It will also showcase its oral platform technology. Keeps Pharma aims to secure collaborations with large pharmaceutical companies. The outreach targets big‑pharma partners seeking innovative therapies. Attendance at BIO USA provides a platform for networking and deal‑making. Success could accelerate the company’s drug development pipeline.